Inactive Instrument

Diaxonhit Share Price Euronext Paris

Equities

FR0004054427

Biotechnology & Medical Research

Financials

Sales 2024 * 138M 150M 11.77B Sales 2025 * 148M 161M 12.63B Capitalization 146M 158M 12.42B
Net income 2024 * 9M 9.77M 768M Net income 2025 * 11M 11.94M 938M EV / Sales 2024 * 0.98 x
Net cash position 2024 * 9.9M 10.74M 845M Net cash position 2025 * 32.8M 35.59M 2.8B EV / Sales 2025 * 0.76 x
P/E ratio 2024 *
15.3 x
P/E ratio 2025 *
12 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 61.33%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 18/06/17
Director of Finance/CFO 43 30/09/22
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 18/06/17
Director/Board Member 68 03/11/09
Director/Board Member 67 14/06/17
More insiders
Eurobio Scientific is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The group has approximately 320 employees, three production units based in the Paris region, in Germany and in the United States, and subsidiaries in Milan in Italy, Dorking in the United Kingdom, Sissach in Switzerland, Bünde in Germany and Utrecht in the Netherlands.
Calendar
More about the company